<DOC>
	<DOCNO>NCT01112865</DOCNO>
	<brief_summary>Convenience preference new Mark VII pen compare current Genotropin pen assess use questionaire . expect new pen prefer least different current pen .</brief_summary>
	<brief_title>Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<criteria>Age great equal 8 year . Subjects start treatment growth hormone ( Genotropin ) first time . Subjects PraderWilli syndrome chronic renal insufficiency . Subjects caregiver , opinion investigator able adequately participate study . Subjects chronic systemic disorder , diabetes heart disease .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Growth Hormone Deficiency</keyword>
	<keyword>Somatropin</keyword>
	<keyword>Injection Pen</keyword>
	<keyword>Medical Device</keyword>
	<keyword>Cross Over Study</keyword>
	<keyword>Preference</keyword>
	<keyword>Convenience</keyword>
	<keyword>Children</keyword>
	<keyword>Dyads</keyword>
	<keyword>Adults</keyword>
</DOC>